Literature DB >> 18625417

Nutrition and dietary supplements in motor neuron disease.

Jeffrey Rosenfeld1, Amy Ellis.   

Abstract

Compromised nutrition leading to weight loss is a common and significant problem in the amyotrophic lateral sclerosis (ALS) patient population. The benefit of aggressive and early nutritional therapy can profoundly influence the disease course, quality of life, and survival. This article reviews the role of nutrition, both as sustenance and treatment for patients who have ALS. Self-medication with dietary supplements has become increasingly popular within this patient population. Despite their popularity, the efficacy of these compounds has been largely unsupported by formal clinical trials. Available data will be highlighted to provide a basis upon which to advise patients requesting guidance.

Entities:  

Mesh:

Year:  2008        PMID: 18625417      PMCID: PMC2631353          DOI: 10.1016/j.pmr.2008.03.001

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  92 in total

1.  Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.

Authors:  R J Ferrante; S E Browne; L A Shinobu; A C Bowling; M J Baik; U MacGarvey; N W Kowall; R H Brown; M F Beal
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

Review 2.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

3.  Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.

Authors:  M E Gurney; F B Cutting; P Zhai; A Doble; C P Taylor; P K Andrus; E D Hall
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

4.  Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.

Authors:  L Mazzini; T Corrà; M Zaccala; G Mora; M Del Piano; M Galante
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

5.  Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?

Authors:  C R Reider; G W Paulson
Journal:  Arch Neurol       Date:  1997-05

6.  Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with atp-dependent glutamate uptake.

Authors:  C J Xu; W E Klunk; J N Kanfer; Q Xiong; G Miller; J W Pettegrew
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

7.  Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.

Authors:  E S Louwerse; G J Weverling; P M Bossuyt; F E Meyjes; J M de Jong
Journal:  Arch Neurol       Date:  1995-06

8.  Vitamin A and E levels are normal in amyotrophic lateral sclerosis.

Authors:  Y Iwasaki; K Ikeda; M Kinoshita
Journal:  J Neurol Sci       Date:  1995-10       Impact factor: 3.181

9.  Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture.

Authors:  J P Bolaños; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

10.  Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.

Authors:  E J Kasarskis; S Berryman; J G Vanderleest; A R Schneider; C J McClain
Journal:  Am J Clin Nutr       Date:  1996-01       Impact factor: 7.045

View more
  10 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Authors:  Petra Kaufmann; John L P Thompson; Gilberto Levy; Richard Buchsbaum; Jeremy Shefner; Lisa S Krivickas; Jonathan Katz; Yvonne Rollins; Richard J Barohn; Carlayne E Jackson; Ezgi Tiryaki; Catherine Lomen-Hoerth; Carmel Armon; Rup Tandan; Stacy A Rudnicki; Kourosh Rezania; Robert Sufit; Alan Pestronk; Steven P Novella; Terry Heiman-Patterson; Edward J Kasarskis; Erik P Pioro; Jacqueline Montes; Rachel Arbing; Darleen Vecchio; Alexandra Barsdorf; Hiroshi Mitsumoto; Bruce Levin
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

3.  Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study.

Authors: 
Journal:  Lancet Neurol       Date:  2015-05-28       Impact factor: 44.182

Review 4.  Multidisciplinary Interventions in Motor Neuron Disease.

Authors:  U E Williams; E E Philip-Ephraim; S K Oparah
Journal:  J Neurodegener Dis       Date:  2014-11-18

Review 5.  Potential Preventive Strategies for Amyotrophic Lateral Sclerosis.

Authors:  B Kuraszkiewicz; H Goszczyńska; T Podsiadły-Marczykowska; M Piotrkiewicz; P Andersen; M Gromicho; J Grosskreutz; M Kuźma-Kozakiewicz; S Petri; B Stubbendorf; K Szacka; H Uysal; M de Carvalho
Journal:  Front Neurosci       Date:  2020-05-26       Impact factor: 4.677

Review 6.  Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.

Authors:  Polina S Goncharova; Tatiana K Davydova; Tatiana E Popova; Maxim A Novitsky; Marina M Petrova; Oksana A Gavrilyuk; Mustafa Al-Zamil; Natalia G Zhukova; Regina F Nasyrova; Natalia A Shnayder
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

7.  Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.

Authors:  Sonja Körner; Melanie Hendricks; Katja Kollewe; Antonia Zapf; Reinhard Dengler; Vincenzo Silani; Susanne Petri
Journal:  BMC Neurol       Date:  2013-07-12       Impact factor: 2.474

8.  Omega-3 Hastens and Omega-6 Delays the Progression of Neuropathology in a Murine Model of Familial ALS.

Authors:  Edward F Boumil; Rishel Brenna Vohnoutka; Yuguan Liu; Sangmook Lee; Thomas B Shea
Journal:  Open Neurol J       Date:  2017-12-22

Review 9.  From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline.

Authors:  Rajka Maria Liscic; Antonella Alberici; Nigel John Cairns; Maurizio Romano; Emanuele Buratti
Journal:  Mol Neurodegener       Date:  2020-06-01       Impact factor: 14.195

10.  Nasal unsedated seated percutaneous endoscopic gastrostomy (nuPEG): a safe and effective technique for percutaneous endoscopic gastrostomy placement in high-risk candidates.

Authors:  Adam McCulloch; Ovishek Roy; Dunecan Massey; Rachel Hedges; Serena Skerratt; Nicola Wilson; Jeremy Woodward
Journal:  Frontline Gastroenterol       Date:  2017-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.